MASE
The "MASE" trademark, serial number 73477665 , was filed on 24th of October 1985 with a mark drawing code of 1000 and its transaction date is 73477665. The attorney assigned is Howard N. Aronson and Nancy Dwyer Chapman and Cathy E. Shore-Sirotin and Renee L. Duff, attorney docket number 10511. Since 2nd of February 2012, the document can be found in the 570 law office in the publication and issue section. The status of the trademark was checked last on 03/23/2007.
The "MASE" trademark, serial number 76642718 , was filed on 13th of July 2005 with a mark drawing code of 4000 and its transaction date is 76642718. Since 6th of January 2012, the document can be found in the M70 law office in the publication and issue section. The employee responsible is LEE, DEBRA ANN and the date it was published for opposition on 04/04/2006. The date when we last checked the status of this trademark was 11/28/2006.
The "MASE" trademark, serial number 85583430 , was filed on 29th of March 2012 with a mark drawing code of 4000 and its transaction date is 85583430. The attorney assigned is Nicole E. Gage, attorney docket number 073044-0138. Since 18th of March 2014, the document can be found in the L50 law office in the publication and issue section. The employee responsible is BERNS, LEE ANNE and the date it was published for opposition on 01/21/2014. The status of the trademark was checked last on 03/18/2014.
The corresponded responsible for this trademark is NICOLE E. GAGE, located at FOLEY & LARDNER LLP, 3000 K STREET N.W., SUITE 600, WASHINGTON, DC 20007-5109.The state or country where the trademark was organized is by Molecular Health Ag. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Dufourstr. 25, 4010 Basel, zip .
| GOODS AND/OR SERVICES | |
| International Class - 035 - Advertising; business management; business administration; office functions. | |
|---|---|
| U.S. Class | 102 - Insurance and Financial |
| Class Status | 6 - Active |
| Status Date | 04/04/2012 |
| Primary Code | 035 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 04/04/2012 |
| Primary Code | 042 |
| International Class - 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 04/04/2012 |
| Primary Code | 044 |
| Goods codes | |
| CC0000 | Color is not claimed as a feature of the mark. |
| GS0351 | Data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer; data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data, comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments |
| GS0421 | Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data, comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; providing medical and scientific research in the fields of pharmaceutical side effects genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, genomic data and genomic sequence analysis for scientific research purposes; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; software as a service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical research purposes; design and development of computer software in the fields of biology, medicine and bioinformatics; design and development of computer software for the integration of patient specific data, molecular test results, clinical studies and scientific results; medical and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others |
| GS0441 | Providing an online database featuring diagnostic and therapeutic medical, pharmaceutical and genomic information; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to the treatment of individual patients; medical and pharmaceutical consulting services in relation to patient medical treatment options and treatment protocols |
| TR0010 | The wording "MASE" has no meaning in a foreign language. |
| FOREGIN REGISTRATION | |
| Foreign Filing Date | 03/06/2012 |
|---|---|
| Foreign Registration Date | 03/06/2012 |
| Foreign Expiration Date | 03/06/2022 |
| Foreign Application Number | 52648/2012 |
| Country | CH |
| Foreign Registration Number | 639808 |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 09/26/2013 | LIE CHECKED SUSP - TO ATTY FOR ACTION | S | RCCK - LIE CHECKED SUSP - TO ATTY FOR ACTION | |
| 03/12/2013 | LETTER OF SUSPENSION E-MAILED | S | GNSL - LETTER OF SUSPENSION E-MAILED | |
| 03/12/2013 | SUSPENSION LETTER WRITTEN | R - Renewal | CNSL - SUSPENSION LETTER WRITTEN | |
| 03/18/2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | E | NOAM | |
| 01/21/2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
| 01/21/2014 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 01/01/2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | E | NONP | |
| 12/17/2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 12/13/2013 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 12/13/2013 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
| 12/13/2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEN | |
| 12/13/2013 | EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEA - EXAMINERS AMENDMENT E-MAILED | |
| 12/13/2013 | EXAMINERS AMENDMENT -WRITTEN | R - Renewal | CNEA - EXAMINERS AMENDMENT -WRITTEN | |
| 10/31/2013 | NOTIFICATION OF PRIORITY ACTION E-MAILED | O - Outgoing Correspondence | GPRN | |
| 10/31/2013 | PRIORITY ACTION E-MAILED | O - Outgoing Correspondence | GPRA - PRIORITY ACTION E-MAILED | |
| 10/31/2013 | PRIORITY ACTION WRITTEN | R - Renewal | CPRA - PRIORITY ACTION WRITTEN | |
| 10/30/2013 | DATA MODIFICATION COMPLETED | I - Incoming Correspondence | DMCC - DATA MODIFICATION COMPLETED | |
| 10/02/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 10/01/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 10/01/2013 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | I - Incoming Correspondence | ERSI | |
| 09/24/2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 03/12/2013 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS3 | |
| 03/11/2013 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
| 03/11/2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEN | |
| 03/11/2013 | EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEA - EXAMINERS AMENDMENT E-MAILED | |
| 03/11/2013 | EXAMINERS AMENDMENT -WRITTEN | R - Renewal | CNEA - EXAMINERS AMENDMENT -WRITTEN | |
| 03/05/2013 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
| 03/05/2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEN | |
| 03/05/2013 | EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEA - EXAMINERS AMENDMENT E-MAILED | |
| 03/05/2013 | EXAMINERS AMENDMENT -WRITTEN | R - Renewal | CNEA - EXAMINERS AMENDMENT -WRITTEN | |
| 01/30/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 01/30/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 01/22/2013 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 01/22/2013 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 01/18/2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 01/18/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 07/20/2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 07/20/2012 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 07/20/2012 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 07/10/2012 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 04/04/2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 04/02/2012 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.